These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30682248)

  • 21. New treatments for chronic obstructive pulmonary disease.
    Barnes PJ
    Ann Ist Super Sanita; 2003; 39(4):573-82. PubMed ID: 15098577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New drugs for exacerbations of chronic obstructive pulmonary disease.
    Hansel TT; Barnes PJ
    Lancet; 2009 Aug; 374(9691):744-55. PubMed ID: 19716967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for novel COPD therapies.
    Barnes PJ
    Pulm Pharmacol Ther; 1999; 12(2):67-71. PubMed ID: 10373383
    [No Abstract]   [Full Text] [Related]  

  • 24. Update on molecular mechanisms of corticosteroid resistance in chronic obstructive pulmonary disease.
    Jiang Z; Zhu L
    Pulm Pharmacol Ther; 2016 Apr; 37():1-8. PubMed ID: 26805715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
    Pelaia G; Muzzio CC; Vatrella A; Maselli R; Magnoni MS; Rizzi A
    Expert Opin Pharmacother; 2015; 16(13):2009-21. PubMed ID: 26194120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment options for moderate-to-very severe chronic obstructive pulmonary disease.
    Cazzola M; Rogliani P; Ora J; Matera MG
    Expert Opin Pharmacother; 2016; 17(7):977-88. PubMed ID: 26894516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
    López-Campos JL; Calero Acuña C
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bronchodilators in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Buhl R; Rabe KF; Vogelmeier C; Welte T
    Med Klin (Munich); 2005 May; 100(5):246-54. PubMed ID: 15902378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frontrunners in novel pharmacotherapy of COPD.
    Barnes PJ
    Curr Opin Pharmacol; 2008 Jun; 8(3):300-7. PubMed ID: 18457992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New therapies for chronic obstructive pulmonary disease.
    Krishna G; Sankaranarayanan V; Chitkara RK
    Expert Opin Investig Drugs; 2004 Mar; 13(3):255-67. PubMed ID: 15013944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roflumilast in chronic obstructive pulmonary disease: evidence from large trials.
    Cazzola M; Picciolo S; Matera MG
    Expert Opin Pharmacother; 2010 Feb; 11(3):441-9. PubMed ID: 20102307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study.
    Di Martino M; Agabiti N; Bauleo L; Kirchmayer U; Cascini S; Pistelli R; Colamesta V; Patorno E; Pinnarelli L; Fusco D; Perucci CA; Davoli M;
    COPD; 2014 Aug; 11(4):414-23. PubMed ID: 24090036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
    Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Medications in Chronic Obstructive Pulmonary Disease: Use and Outcomes.
    Roche N
    Clin Chest Med; 2020 Sep; 41(3):485-494. PubMed ID: 32800201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New bronchodilators and combinations in COPD treatment].
    Günay S; Sarıaydın M; Yılmaz Demirci N
    Tuberk Toraks; 2016 Sep; 64(3):240-245. PubMed ID: 28366158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New drugs under development for COPD.
    Lo Bello F; Hansbro PM; Donovan C; Coppolino I; Mumby S; Adcock IM; Caramori G
    Expert Opin Emerg Drugs; 2020 Dec; 25(4):419-431. PubMed ID: 32882146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future treatment of chronic obstructive pulmonary disease.
    Di Maria G; Spicuzza L; Mazzarella G
    Monaldi Arch Chest Dis; 2002; 57(3-4):200-5. PubMed ID: 12619385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Naringenin as a Promising Treatment Option for COPD Based on Literature Review and Network Pharmacology.
    Chen Z; Chen P; Wu H; Shi R; Su W; Wang Y; Li P
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation.
    Loukides S; Bartziokas K; Vestbo J; Singh D
    Curr Drug Targets; 2013 Feb; 14(2):235-45. PubMed ID: 23256720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Phosphodiesterase-4 inhibitors: roflumilast].
    Izquierdo Alonso JL
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():22-30. PubMed ID: 21596170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.